Result of General Meeting
In brief · summary, not quotable
4basebio PLC announced that all resolutions proposed at its Extraordinary General Meeting held on October 10, 2025, were duly passed.
Full announcement
Select text to share a quote on X · sign in to keep highlights & notes in your 4BB notes
Cambridge, UK, 10 October 2025 - 4basebio PLC (AIM: 4BB), an innovation-led provider of novel synthetic DNA products and a non-viral, thermostable nucleic acid delivery platform announces that all of the resolutions proposed at its Extraordinary General Meeting held earlier today were duly passed.
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.